Belpointe Asset Management LLC Boosts Stock Holdings in Omega Healthcare Investors, Inc. $OHI

Key Points

• Belpointe Asset Management LLC increased its stake in Omega Healthcare Investors by 57.0%, owning 16,246 shares valued at $619,000 after purchasing an additional 5,896 shares in the first quarter.
• Omega Healthcare Investors reported an EPS of $0.77 for the last quarter, exceeding analysts' expectations of $0.45, with a revenue of $235.60 million, up 11.8% from the previous year.
• A quarterly dividend of $0.67 per share was declared, resulting in a 6.3% yield, with a payout ratio currently at 165.43%.

Belpointe Asset Management LLC raised its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 57.0% during the first quarter, according to its most recent filing with the SEC. The firm owned 16,246 shares of the real estate investment trust's stock after purchasing an additional 5,896 shares during the period. Belpointe Asset Management LLC's holdings in Omega Healthcare Investors were worth $619,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in Omega Healthcare Investors by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock valued at $1,506,250,000 after purchasing an additional 1,492,904 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Omega Healthcare Investors by 2.9% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust's stock worth $156,162,000 after purchasing an additional 114,665 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Omega Healthcare Investors by 4.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust's stock worth $154,533,000 after purchasing an additional 165,554 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Omega Healthcare Investors by 6.4% in the 1st quarter. Bank of New York Mellon Corp now owns 3,123,152 shares of the real estate investment trust's stock worth $118,930,000 after purchasing an additional 188,481 shares in the last quarter. Finally, AQR Capital Management LLC boosted its stake in Omega Healthcare Investors by 430.8% in the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock worth $108,989,000 after purchasing an additional 2,322,878 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Insider Buying and Selling

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.50% of the stock is owned by corporate insiders.

Omega Healthcare Investors Trading Down 0.0%

Shares of OHI opened at $42.49 on Friday. The firm has a 50-day moving average price of $40.26 and a 200 day moving average price of $38.24. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $12.53 billion, a P/E ratio of 26.23, a P/E/G ratio of 2.23 and a beta of 0.71.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last posted its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. During the same quarter in the prior year, the company posted $0.71 earnings per share. Omega Healthcare Investors's revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.3%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is currently 165.43%.

Analyst Ratings Changes

Several analysts have commented on OHI shares. Scotiabank lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research note on Thursday, August 28th. Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Truist Financial boosted their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Mizuho boosted their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a report on Thursday. Finally, Wells Fargo & Company boosted their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, August 27th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, Omega Healthcare Investors presently has an average rating of "Moderate Buy" and a consensus target price of $43.75.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.